AstraZeneca’s leukemia product approved in China
The Anglo-Swedish pharma company, AstraZeneca’s Calquence product has been approved in China for the treatment of adults with leukemia. The company stated this on Monday, September 4. The product has …
AstraZeneca’s leukemia product approved in China Read More